Skip to content

Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes

The Copenhagen Rehabilitation Trial Part 2: Telemedicine as a Means to Achieve Good Diabetes Control Among Patients With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01688778
Enrollment
165
Registered
2012-09-20
Start date
2012-06-30
Completion date
2015-04-28
Last updated
2018-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence, Poor Glycemic Control, Type 2 Diabetes

Keywords

Type 2 diabetes, Quality of life, Lifestyle intervention, Telemedicine, Videoconference

Brief summary

The aim of the study is to investigate the effect of telemedicine among the group of type-2-diabetics who, despite rehabilitation, remain poorly regulated. To describe the patients with regards to vulnerability and social resources and to determine wich groups benefit the most from telemedicine.

Detailed description

Type-2-diabetes is a growing healthcare problem. Both because of the increasing amount of patients and because of the complications of diabetes. Non-pharmacological treatment is considered fundamental in the treatment of patients with type-2-diabetes. In the Community of Copenhagen, all patients diagnosed with diabetes receive rehabilitation. The rehabilitation consists of counseling with regards to nutrition, physical activity, smoking cessation and education about diabetes. Some patients however, remain poorly regulated despite rehabilitation as well as pharmacological treatment. A total number of 165 patients will be randomized to intervention group or standard care.

Interventions

BEHAVIORALTelemedicine

Monthly video consultations with a nurse as add-on to standard treatment. The nurse has access to bloodsugar- bloodpressure and weight measurements uploaded by the participants to a tablet computer directly from the devices. Patients on Insulin measure bloodsugar twice a day (fasting and before their evening meal). Patients not on Insulin measure bloodsugar once a week (fasting and before their evening meal). All participants measure bloodpressure and weight once a week. The intervention lasts 32 weeks.

Sponsors

The Health and Care Committee, Copenhagen City Council
CollaboratorUNKNOWN
Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* HbA1c \> 7,5% * BMI \> 25 * Spoken danish * Completed a rehabilitation program more than 6 months ago

Exclusion criteria

* HbA1c \< 7,5% * BMI \< 25 * Need of interpreter

Design outcomes

Primary

MeasureTime frame
Changes in HbA1cBaseline, 16 weeks, 32 weeks, 6 months after intervention

Secondary

MeasureTime frame
BloodpressureBaseline, 32 weeks
Waist circumferenceBaseline, 32 weeks
Hip circumferenceBaseline, 32 weeks
Body mass indexBaseline, 32 weeks
Use of medicationBaseline, 32 weeks
Fasting total cholesterol, LDL, HDL, triglyceridesBaseline, 32 weeks
Beta-cell function test (HOMA)Baseline, 32 weeks
WeightBaseline, 32 weeks
Physical activityBaseline, 32 weeks
Change in quality of lifeBaseline, 32 weeks

Other

MeasureTime frame
Number of visits at the outpatient department32 weeks
Number of visits at GP32-weeks
Number of visits at the emergency32 weeks
Number of hospital admissions32 weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026